<DOC>
	<DOCNO>NCT01514877</DOCNO>
	<brief_summary>The aim study explore efficacy toxicity icotinib combine WBRT treat patient multiple brain metastasis NSCLC .</brief_summary>
	<brief_title>Icotinib Combined With Whole Brain Radiotherapy Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Brain metastasis occur 25-40 % patient non-small cell lung cancer ( NSCLC ) . It one primary reason result treatment failure death . Whole-brain radiation therapy ( WBRT ) standard approach treatment multiple brain metastasis NSCLC . Regardless treatment brain metastasis WBRT combine systemic chemotherapy , outcomes NSCLC brain metastasis still poor . Epidermal growth factor receptor tyrosine kinase inhibitor ( EGFR-TKIs ) pas blood-brain barrier show promising antitumor activity brain metastasis NSCLC . Icotinib show nearly effect gefitinib advance NSCLC patient fail chemotherapy .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Cytologic histological diagnosis nonsmall cell lung cancer Patients disease progression systemic chemotherapy twodrug combination regimens include platinum agent patient EGFR mutation status treat Patients diagnosed multiple brain metastasis first time 4 week Diagnosis brain metastasis make base Magnetic resonance imaging ( MRI ) . Doctors consider patient benefit WBRT No prior brain radiotherapy ECOG performance status 02 age:1875 year Neutrophil count ≥1.5×10 9th power/L platelets≥100×10 9th power/L . hemoglobin ≥90 g/L Hepatic : total bilirubin less equal 1.5 time upper limit normal ( ULN ) Alanine transaminase ( ALT ) aspartate transaminase ( AST ) less equal 2.5 time ULN ( less equal 5 time ULN case know liver involvement ) Renal : Serum Creatinine less equal 1.5 time upper limit normal ( ULN ) Patients measurable brain metastasis accord Response Evaluation Criteria Solid Tumors ( RECIST ) criterion Patients must sign informed consent indicate aware investigational nature study Prior brain radiation therapy Solitary brain metastasis accord Magnetic resonance imaging ( MRI ) Mort 3 extracranial organ metastatic lesion Prior invasive malignancy ( skin basal cell cancer , carcinoma situ cervix permissible ) . pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>tumor metastatic brain</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>Icotinib</keyword>
</DOC>